Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
DSM chairman Simon de Bree commented on the lucrative nature of the union in a 1998 Chemical Market Reporter article: "There are no other companies which are spread across such a range of clearly-defined technologies, pooled into a single source.
In 2000 DSM reported record financial results--sales of EUR 8 billion and net profit of EUR 580 million.
DSM's 100th anniversary celebration in 2002 was marked by the sale of its petrochemicals business.
2002: DSM sells its petrochemicals business to SABIC.
With "Vision 2005," DSM is continuing its focus to take a leading worldwide position in activities with greater added value, strong growth, and stable results.
During this time period, DSM launched its "Vision 2005: Focus and Value" strategy, which was centered on transforming the company into a leading specialty chemicals firm focused on life science products and performance materials.
We’re so convinced of the value of doing well by doing good that our strategy is aligned with the Sustainable Development Goals (SDGs) outlined by the United Nations in 2015.
DSM announces its 'Strategy 2018: Driving Profitable Growth' to capture the full potential of the portfolio created and translate this into improved financial results, focusing on organic sales growth, reducing costs and strict capital allocation.
Rate DSM Pharmaceuticals Inc's efforts to communicate its history to employees.
Do you work at DSM Pharmaceuticals Inc?
Does DSM Pharmaceuticals Inc communicate its history to new hires?
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| The Ritedose | 1995 | $14.0M | 182 | - |
| LYKA Labs | - | - | 99 | - |
| Amtek Technologies | - | $284.9K | 5 | - |
| ALZA Corporation | 1968 | $200.0M | 10,000 | - |
| Catalent Pharma Solutions | 2007 | $4.4B | 14,000 | 378 |
| West-Ward Pharmaceuticals | 1946 | $150.0M | 249 | 55 |
| Pharmaceutics International | 1994 | $367.8M | 1,000 | 9 |
| DPT Laboratories | 1938 | $320.0M | 510 | 1 |
| Coldstream Labs | 2007 | $3.5M | 50 | - |
| Immunomedics | 1982 | $21.5M | 185 | - |
Zippia gives an in-depth look into the details of DSM Pharmaceuticals Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about DSM Pharmaceuticals Inc. The employee data is based on information from people who have self-reported their past or current employments at DSM Pharmaceuticals Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by DSM Pharmaceuticals Inc. The data presented on this page does not represent the view of DSM Pharmaceuticals Inc and its employees or that of Zippia.
DSM Pharmaceuticals Inc may also be known as or be related to DSM Pharmaceuticals Inc.